切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2020, Vol. 14 ›› Issue (02) : 117 -121. doi: 10.3877/cma.j.issn.1674-3946.2020.02.003

所属专题: 述评/论坛 总编推荐 文献

专家论坛

减重代谢手术对心脑血管不良事件的影响
程中1,(), 陈珊珊1, 赵晨阳1, 杜潇1   
  1. 1. 四川大学华西医院胃肠外科
  • 收稿日期:2019-08-26 出版日期:2020-04-26
  • 通信作者: 程中

The effects of bariatric and metabolic surgery on cardiac-cerebrovascular adverse events

Zhong Cheng1,(), Shanshan Chen1, Chenyang Zhao1, Xiao Du1   

  1. 1. Department of Gastrointestinal Surgery, West China hospital, Sichuan University, Sichuan 610041, China
  • Received:2019-08-26 Published:2020-04-26
  • Corresponding author: Zhong Cheng
  • About author:
    Corresponding author: Cheng Zhong , Email:
  • Supported by:
    Wu Jieping Medical Foundation(NO.320.2710.1810); National Natural Science Foundation of China(NO.81502613)
引用本文:

程中, 陈珊珊, 赵晨阳, 杜潇. 减重代谢手术对心脑血管不良事件的影响[J/OL]. 中华普外科手术学杂志(电子版), 2020, 14(02): 117-121.

Zhong Cheng, Shanshan Chen, Chenyang Zhao, Xiao Du. The effects of bariatric and metabolic surgery on cardiac-cerebrovascular adverse events[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2020, 14(02): 117-121.

肥胖是诱发心脑血管不良事件的重要原因之一,减重代谢手术是近年来新兴的被证实可安全、有效减轻患者体重,并改善肥胖相关合并症如2型糖尿病、高血压、代谢综合征等的一种方式。有研究发现减重代谢手术可改善心脑血管不良事件危险因素,如炎症、高血压、血脂异常等,但减重代谢手术可否显著降低肥胖患者心脑血管不良事件尚不明确。本文通过回顾相关文献报道,了解减重代谢手术对肥胖患者心脑血管不良事件的影响,进一步阐明减重代谢手术的疗效及应用价值。

Obesity is one of the most significant reasons to induce cardiac-cerebrovascular adverse events. Bariatric and metabolic surgery is increasingly recognized as a safe and effective intervention to achieve marked weight loss, and improvement in obesity-related complications, including type2 diabetes mellitus, hypertension and metabolic syndrome. There is observational evidence that bariatric and metabolic surgery in obese patients could decrease risk factors, including inflammation, hypertension, dyslipidaemia, however, further studies are still needed to indentify the correlation of bariatric and metabolic surgery and reduced rates of cardiac-cerebrovascular adverse events. This article summarizes the effects of bariatric and metabolic surgery on cardiac-cerebrovascular adverse events in obese patients in order to illustrate its clinical significance and application value.

表1 肥胖对心脑血管事件危险因素的影响
表2 肥胖对心脑血管事件的影响
表3 减重代谢手术对心脑血管事件的影响
作者,年份 手术组纳入患者数 对照组纳入患者数 平均跟踪随访时间 结果(手术组vs.对照组)
Sjostrom, L 2007[15] 2010 2037 10.9年 累计死亡率HR 0.76 (95% CI 0.59~0.99; P=0.04)
因心肌梗死死亡:0.65%(13/2010) vs.1.23%(25/2037)
因心力衰竭死亡:0.10%(2/2010) vs. 0.25%(5/2037)
因卒中死亡:2.98%(6/2010) vs.2.95%(6/2037)
Sjostrom, L 2012[16] 2010 2037 14.7年 总心脑血管事件:9.90%(199/2010) vs. 11.49%(234/2037)
调整后HR 0.67(95% CI 0.54~0.83; P<0.001)
总心肌梗死:6.07%(122/2010) vs. 6.68%(136/2037)
调整后HR 0.71(95% CI 0.54~0.94; P=0.02)
因心肌梗死死亡:1.09%(22/2010) vs. 1.82%(37/2037)
调整后HR 0.52 (95% CI 0.31~0.89; P=0.02)
总卒中:4.63%(93/2010) vs. 5.45%(111/2037)
调整后HR 0.66 (95% CI 0.49~0.90; P=0.008)
因卒中死亡:0.29(6/2010) vs. 0.59%(12/2037)
调整后HR 0.34(95% CI 0.12~1.00; P=0.05)
Johnson 2013[17] 2580 13371 19.0~21.2月 大血管事件(心肌梗死、卒中、死亡)HR 0.39 (95% CI 0.29~0.51)
心肌梗死:0.31%(8/2580) vs.1.80%(241/13371)
心力衰竭:1.35%(35/2580) vs.10.00%(1338/13371)
卒中:0.43%(11/2580) vs.1.60%(214/13371)
死亡:1.59%(41/2580) vs.7.37%(985/13371)
Scott 2013[18] 4747 对照组1(行关节置换术等骨科手术): 3066对照组2(行胆囊切除术等胃肠道手术): 1327 13.7~25.8月 心肌梗死(5年无事件生存率):
手术组vs.对照组1:(92.4±1.0)% vs.(85.6±1.2)% (P<0.001)
手术组vs.对照组2:(92.4±1.0)% vs.(83.9±1.8)% (P<0.001)
卒中(5年无事件生存率):手术组vs.对照组1:(98.1±0.5)% vs.(96.1±0.7)% (P<0.013)
手术组vs.对照组2:(98.1±0.5)% vs.(96.1±1.0)% (P<0.022)
死亡(5年无事件生存率):手术组vs.对照组1:(92.7±1.0)% vs.(84.2±1.3)% (P<0.001)
手术组vs.对照组2:(92.7±1.0)% vs.(77.8±2.0)% (P<0.001)
Eliasson, B 2015[19] 6132 6132 3.5年 因心脑血管事件死亡总数:0.21%(13/6132) vs. 1.09%(67/6132)
调整后HR 0.41 (95% CI 0.19~0.90)
心肌梗死:0.39%(24/6132) vs.1.09%(67/6132)
调整后HR 0.51 (95% CI 0.29~0.91)
表4 减重代谢手术对心功能指标的影响
[1]
American Diabetes Association.7.Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2018[J].Diabetes Care,2018,41(Suppl 1):S65-S72.
[2]
Emerging Risk Factors Collaboration,Wormser D,Kaptoge S,et al.Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies[J].Lancet,2011,377(9771):1085-1095.
[3]
Nguyen NT,Magno CP,Lane KT,et al.Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004[J].J Am Coll Surg,2008,207(6):928-934.
[4]
Anari R,Amani R,Latifi SM,et al.Association of obesity with hypertension and dyslipidemia in type 2 diabetes mellitus subjects[J].Diabetes Metab Syndr,2017,11(1):37-41.
[5]
Horvei LD,Grimnes G,Hindberg K,et al.C-reactive protein, obesity, and the risk of arterial and venous thrombosis[J].J Thromb Haemost,2016,14(8):1561-1571.
[6]
Strazzullo P,D’Elia L,Cairella G,et al.Excess body weight and incidence of stroke: meta-analysis of prospective studies with 2 million participants[J].Stroke,2010,41(5):e418-e426.
[7]
Hagg S,Fall T,Ploner A,et al.Adiposity as a cause of cardiovascular disease: a Mendelian randomization study[J].Int J Epidemiol,2015,44(2):578-586.
[8]
Baena-Diez JM,Byram AO,Grau M,et al.Obesity is an independent risk factor for heart failure: Zona Franca Cohort study[J].Clin Cardiol,2010,33(12):760-764.
[9]
Miller GD,Nicklas BJ,Fernandez A.Serial changes in inflammatory biomarkers after Roux-en-Y gastric bypass surgery[J].Surg Obes Relat Dis,2011,7(5):618-624.
[10]
Dunkle-Blatter SE,St Jean MR,Whitehead C,et al.Outcomes among elderly bariatric patients at a high-volume center[J].Surg Obes Relat Dis,2007,3(2):163-169;discussion 169-170.
[11]
Sjostrom L,Lindroos AK,Peltonen M,et al.Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery[J].N Engl J Med,2004,351(26):2683-2693.
[12]
Gloy VL,Briel M,Bhatt DL,et al.Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials[J].BMJ,2013,347:f5934.
[13]
Afshinnia F,Wilt TJ,Duval S,et al.Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts[J].Nephrol Dial Transplant,2010,25(4):1173-1183.
[14]
Merlotti C,Ceriani V,Morabito A,et al.Bariatric surgery and diabetic retinopathy: a systematic review and meta-analysis of controlled clinical studies[J].Obes Rev,2017,18(3):309-316.
[15]
Sjostrom L,Narbro K,Sjostrom CD,et al.Effects of bariatric surgery on mortality in Swedish obese subjects[J].N Engl J Med,2007,357(8):741-752.
[16]
Sjostrom L,Peltonen M,Jacobson P,et al.Bariatric surgery and long-term cardiovascular events[J]. JAMA,2012,307(1):56-65.
[17]
Johnson BL,Blackhurst DW,Latham BB,et al.Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus[J].J Am Coll Surg,2013,216(4):545-556;discussion 556-558.
[18]
Scott JD,Johnson BL,Blackhurst DW,et al.Does bariatric surgery reduce the risk of major cardiovascular events? A retrospective cohort study of morbidly obese surgical patients[J].Surg Obes Relat Dis,2013,9(1):32-39.
[19]
Eliasson B,Liakopoulos V,Franzen S,et al.Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study[J].Lancet Diabetes Endocrinol,2015,3(11):847-854.
[20]
Owan T,Avelar E,Morley K,et al.Favorable changes in cardiac geometry and function following gastric bypass surgery: 2-year follow-up in the Utah obesity study[J].J Am Coll Cardiol,2011,57(6):732-739.
[21]
Vest AR,Patel P,Schauer PR,et al.Clinical and Echocardiographic Outcomes After Bariatric Surgery in Obese Patients With Left Ventricular Systolic Dysfunction[J].Circ Heart Fail,2016,9(3):e002260.
[1] 向韵, 卢游, 杨凡. 全氟及多氟烷基化合物暴露与儿童肥胖症相关性研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 569-574.
[2] 陈嘉婷, 杜美君, 石冰, 黄汉尧. 母体系统性疾病对新生儿唇腭裂发生的影响[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(04): 262-268.
[3] 杨波, 胡旭, 何金艳, 谢铭. 腹腔镜袖状胃切除术管胃固定研究现状[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 452-455.
[4] 吉顺富, 汤晓燕, 徐进. 腹腔镜近端胃癌根治术中拓展胃后间隙在肥胖患者中的应用研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 393-396.
[5] 玉素江·图荪托合提, 韩琦, 麦麦提艾力·麦麦提明, 黄旭东, 王浩, 克力木·阿不都热依木, 艾克拜尔·艾力. 腹腔镜袖状胃切除或联合食管裂孔疝修补术对肥胖症合并胃食管反流病的中期疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 501-506.
[6] 刘见, 杨晓波, 何均健, 等. 应用电钩三孔法腹腔镜袖状胃切除术[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(06): 363-364.
[7] 刘辉, 海燕. 集束化护理在预防减重代谢手术患者术中压力性损伤中的应用[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(03): 169-173.
[8] 中国医师协会外科医师分会肥胖代谢病综合管理与护理专家工作组, 中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 中国肥胖代谢外科研究协作组. 肥胖代谢外科医学科普中国专家共识(2024 版)[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 227-234.
[9] 李兆, 李兆鹏, 宋逸, 郭栋, 陈栋, 李宇. 腹腔镜袖状胃切除术后残胃容积的测量方案及评价[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 242-247.
[10] 中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 中国医师协会外科医师分会胃食管反流疾病诊疗外科专家工作组, 日本肥胖治疗学会, 韩国减重与代谢外科学会. 袖状胃切除术患者胃食管反流病诊治专家共识(2024版)[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(03): 145-162.
[11] 王思奇, 张念荣, 周彪, 刘宝胤, 孟化. 肥胖与胆囊疾病研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(03): 177-183.
[12] 崔磊, 徐东升. 减重手术治疗肥胖患者胰岛素抵抗的研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(02): 127-132.
[13] 邢颖, 闫文貌. 单孔腹腔镜袖状胃切除术发展现状[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(02): 133-137.
[14] 颜宥彤, 赵锐, 万谦益, 张贵祥, 沈弘毅, 程中, 陈亿. GLP-1受体激动剂——司美格鲁肽的应用及安全性[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(02): 88-93.
[15] 周彪, 李政奇, 孟化. 肥胖与内镜下减重治疗研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(02): 100-107.
阅读次数
全文


摘要